The Involvement of Smooth Muscle, Striated Muscle, and the Myocardium in Scleroderma: A Review
- PMID: 36233313
- PMCID: PMC9569846
- DOI: 10.3390/ijms231912011
The Involvement of Smooth Muscle, Striated Muscle, and the Myocardium in Scleroderma: A Review
Abstract
Systemic sclerosis (SSc) is a complex autoimmune disease characterized by heterogeneous changes involving numerous organs and systems. The currently available data indicate that muscle injury (both smooth and striated muscles) is widespread and leads to significant morbidity, either directly or indirectly. From the consequences of smooth muscle involvement in the tunica media of blood vessels or at the level of the digestive tract, to skeletal myopathy (which may be interpreted strictly in the context of SSc, or as an overlap with idiopathic inflammatory myopathies), muscular injury in scleroderma translates to a number of notable clinical manifestations. Heart involvement in SSc is heterogenous depending on the definition used in the various studies. The majority of SSc patients experience a silent form of cardiac disease. The present review summarizes certain important features of myocardial, as well as smooth and skeletal muscle involvement in SSc. Further research is needed to fully describe and understand the pathogenic pathways and the implications of muscle involvement in scleroderma.
Keywords: myositis; sarcopenia; skeletal muscle; smooth muscle; systemic sclerosis.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosis.Arthritis Res Ther. 2022 Apr 11;24(1):84. doi: 10.1186/s13075-022-02768-z. Arthritis Res Ther. 2022. PMID: 35410246 Free PMC article.
-
Clinical and laboratory features of scleroderma patients developing skeletal myopathy.Clin Rheumatol. 2005 Apr;24(2):99-102. doi: 10.1007/s10067-004-0975-7. Epub 2004 Aug 20. Clin Rheumatol. 2005. PMID: 15322944
-
Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology.Arthritis Res Ther. 2014 May 13;16(3):R111. doi: 10.1186/ar4562. Arthritis Res Ther. 2014. PMID: 24886750 Free PMC article.
-
Systemic sclerosis-associated myopathy.Ann N Y Acad Sci. 2007 Jun;1108:268-82. doi: 10.1196/annals.1422.029. Ann N Y Acad Sci. 2007. PMID: 17899625 Review.
-
Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases.Autoimmun Rev. 2023 May;22(5):103311. doi: 10.1016/j.autrev.2023.103311. Epub 2023 Mar 7. Autoimmun Rev. 2023. PMID: 36889657 Review.
Cited by
-
Computed tomography-derived quantitative imaging biomarkers enable the prediction of disease manifestations and survival in patients with systemic sclerosis.RMD Open. 2025 Jun 25;11(2):e005090. doi: 10.1136/rmdopen-2024-005090. RMD Open. 2025. PMID: 40562681 Free PMC article.
-
Right Ventricular Morphology and Function after Exercise Training in People with Systemic Sclerosis: A Randomized Controlled Pilot Study.Life (Basel). 2023 Feb 15;13(2):545. doi: 10.3390/life13020545. Life (Basel). 2023. PMID: 36836902 Free PMC article.
-
miR-27b-3p reduces muscle fibrosis during chronic skeletal muscle injury by targeting TGF-βR1/Smad pathway.J Orthop Surg Res. 2024 Jun 2;19(1):329. doi: 10.1186/s13018-024-04733-9. J Orthop Surg Res. 2024. PMID: 38825706 Free PMC article.
-
Serum Metabolomic Profiling Reveals Differences Between Systemic Sclerosis Patients with Polyneuropathy.Int J Mol Sci. 2025 Jul 24;26(15):7133. doi: 10.3390/ijms26157133. Int J Mol Sci. 2025. PMID: 40806267 Free PMC article.
-
Heart involvement in patients with systemic sclerosis-what have we learned about it in the last 5 years.Rheumatol Int. 2024 Oct;44(10):1823-1836. doi: 10.1007/s00296-024-05699-x. Epub 2024 Aug 27. Rheumatol Int. 2024. PMID: 39192021 Free PMC article. Review.
References
-
- Varga J., Trojanowska M., Kuwana M. Pathogenesis of systemic sclerosis: Recent insights of molecular and cellular mechanisms and therapeutic opportunities. J. Scleroderma Relat. Disord. 2017;2:137–152. doi: 10.5301/jsrd.5000249. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical